Table 1.
Selected baseline characteristics and clinical outcomes data for patients who developed cardiac implantable electronic device (CIED) infections (complete cohort of infected patients)
| CRT-P (n = 20) | CRT-D (n = 47) | Total (n = 67) | |||||
|---|---|---|---|---|---|---|---|
| Baseline characteristics | |||||||
| Age, mean ± SD | 71 | ± 10 | 70 | ± 9 | 70 | ± 9 | |
| Female, n (%) | − | − | − | − | 4 | 6% | |
| PADIT score, median (IQR) | 8 | IQR 5–9 | 7 | IQR 6–9 | 7 | IQR 6–9 | |
| Previous procedures, n (%) | |||||||
| 1 | 12 | 52% | 24 | 54.5% | 36 | 54% | |
| ≥2 | 11 | 48% | 20 | 45.5% | 31 | 46% | |
| Procedure type, n (%) | |||||||
| Replacements | 15 | 65% | 29 | 66% | 44 | 66% | |
| Upgrades | 8 | 35% | 15 | 34% | 23 | 34% | |
| Clinical outcomes data | |||||||
| Infection type, n (%) | |||||||
| 17 | 74% | 30 | 68% | 47 | 70% | ||
| Systemic | 6 | 26% | 14 | 32% | 20 | 30% | |
| Hospitalization (days), median (IQR) | 22 | IQR 12–37 | 26 | IQR 15–67 | 25 | IQR 14–43 | |
| ICU stay, n (%) | − | − | − | − | 12 | 18% | |
| Days in the ICU, median (IQR) | − | − | − | − | 8.5 | IQR 3–11.5 | |
| In-hospital mortality, n (%) | − | − | − | − | 7 | 10% | |
Subgroups with <4 patients are not reported due to patient discretion considerations.
CRT-P/-D, cardiac resynchronization therapy pacemaker/-defibrillator; PADIT, prevention of arrhythmia device infection; ICU, intensive care unit.